↓ Skip to main content

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Overview of attention for article published in New England Journal of Medicine, May 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Readers on

mendeley
1756 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Published in
New England Journal of Medicine, May 2014
DOI 10.1056/nejmoa1402582
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 54 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 1,756 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 5 <1%
Japan 4 <1%
Spain 4 <1%
United Kingdom 3 <1%
Brazil 3 <1%
Colombia 2 <1%
Tunisia 1 <1%
Italy 1 <1%
Germany 1 <1%
Other 1 <1%
Unknown 1731 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 234 13%
Student > Ph. D. Student 179 10%
Other 161 9%
Student > Master 143 8%
Student > Bachelor 117 7%
Other 307 17%
Unknown 615 35%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 598 34%
Biochemistry, Genetics and Molecular Biology 129 7%
Agricultural and Biological Sciences 102 6%
Pharmacology, Toxicology and Pharmaceutical Science 63 4%
Chemistry 32 2%
Other 168 10%
Unknown 664 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 374. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2026.
All research outputs
#106,132
of 34,457,357 outputs
Outputs from New England Journal of Medicine
#2,686
of 38,407 outputs
Outputs of similar age
#697
of 274,654 outputs
Outputs of similar age from New England Journal of Medicine
#16
of 260 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,407 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.2. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,654 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 260 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.